£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days · 47 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 26 July 2026 06 August 2026 18 August 2026 29 August 2026 10 September 2026
View at Amazon ↗

Price data last checked 44 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 47 days • 1 price levels

Days at Price
47 days 0 12 24 35 47 £595 Days at Price

Price Analysis

Most common price: £595 (47 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 47 days

Description

This econometric study covers the latent demand outlook for antidepressant pharmaceuticals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for antidepressant pharmaceuticals. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in Japan). This study gives, however, my estimates for the latent demand, or the P.I.E., for antidepressant pharmaceuticals in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
14 November 2016

Similar Products You Might Like

The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
99% match

The 2026-2031 World Outlook for Antidepressant Pharmaceuticals

£885.00 26 Sep 2026
The 2021-2026 World Outlook for Antidepressants
99% match

The 2021-2026 World Outlook for Antidepressants

£795.00 12 Aug 2026
The 2026-2031 World Outlook for Antidepressant Drugs
99% match

The 2026-2031 World Outlook for Antidepressant Drugs

£885.00 15 Aug 2026
The 2026-2031 World Outlook for Antidepressants
99% match

The 2026-2031 World Outlook for Antidepressants

£885.00 15 Aug 2026
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States
99% match

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States

£520.00 25 Aug 2026
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
98% match

The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs

£885.00 15 Aug 2026
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
98% match

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

£885.00 19 Aug 2026
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China
98% match

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China

£495.00 20 Oct 2026
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
98% match

The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States

£520.00 25 Aug 2026
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
98% match

The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics

Price unavailable
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
98% match

The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders

£885.00 14 Aug 2026
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders for US Zip Codes
97% match

The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders for US Zip Codes

£490.00 20 Oct 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
97% match

The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States

£520.00 23 Aug 2026
Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)
97% match

Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)

£100.99 22 Sep 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
97% match

The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States

£520.00 21 Aug 2026
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
97% match

The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants

£795.00 11 Aug 2026
The 2016-2021 Outlook for Drug Stores and Pharmacies in Japan
97% match

The 2016-2021 Outlook for Drug Stores and Pharmacies in Japan

£595.00 20 Sep 2026
The 2016-2021 Outlook for Topical Antiseptic Medications in the United States
97% match

The 2016-2021 Outlook for Topical Antiseptic Medications in the United States

£595.00 25 Aug 2026
Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation
96% match

Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation

Elsevier

£135.69 23 Sep 2026
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
96% match

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan

£595.00 05 Sep 2026
The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
96% match

The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States

£520.00 23 Aug 2026
The 2016-2021 Outlook for Generic Prescription Drugs in the United States
96% match

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

£595.00 21 Aug 2026
The 2016-2021 Outlook for Online Health and Pharmacy-Related Products in Japan
96% match

The 2016-2021 Outlook for Online Health and Pharmacy-Related Products in Japan

£595.00 03 Sep 2026
The 2016-2021 Outlook for Women's Apparel and Accessories in Japan
96% match

The 2016-2021 Outlook for Women's Apparel and Accessories in Japan

£595.00 27 Aug 2026